The global thrombectomy devices market is expected to reach a value of $1.45 billion by 2022, growing at a CAGR of 6.7 percent during the forecast period, according to a new Research and Markets report, “Thrombectomy Devices Market – Global Forecasts to 2022.”

The growing target patient population, ongoing technological advancements, favorable medical reimbursements, rising demand for minimally invasive thrombectomy procedures and increasing healthcare expenditure across emerging markets are some key factors propelling the growth of this market.

The factors such as increasing number of research activities in the field of thrombectomy and expanding application of ultrasound in vascular treatment are expected to offer renewed growth opportunities for market players during the forecast period.

In this report, the market has been segmented on the basis of type, application, end user and region. Based on application, the cardiovascular segment commanded the largest share of the global thrombectomy devices market in 2016.

This large market share is mainly attributed to factors such as increasing prevalence of cardiovascular diseases across major markets, procedural benefits offered by mechanical thrombectomy in cardiac surgeries, higher prevalence of thrombotic diseases among geriatric individuals, and growing preference of surgeons for image-guided and minimally invasive cardiac surgeries.

READ MORE: researchandmarkets.com/research/52xc53/thrombectomy